Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
Assertio Holdings, a pharmaceutical company listed on Nasdaq as ASRT, has announced its participation in the Maxim Group 2024 Healthcare Virtual Summit. The company's CEO, Brendan O'Grady, will engage in a fireside chat discussion on October 15, 2024, at 1:00 pm Eastern Time.
The discussion will be hosted by Maxim Group research analyst Naz Rahman. Investors interested in listening to the event can register through the provided link. This participation underscores Assertio's commitment to engaging with the investment community and showcasing its comprehensive commercial capabilities in offering differentiated pharmaceutical products to patients.
Assertio Holdings, un'azienda farmaceutica quotata al Nasdaq come ASRT, ha annunciato la sua partecipazione al Maxim Group 2024 Healthcare Virtual Summit. Il CEO dell'azienda, Brendan O'Grady, parteciperà a una discussione informale che si terrà il 15 ottobre 2024, alle 13:00 ora orientale.
La discussione sarà condotta dall'analista di ricerca del Maxim Group, Naz Rahman. Gli investitori interessati a seguire l'evento possono registrarsi tramite il link fornito. Questa partecipazione sottolinea l'impegno di Assertio nel coinvolgere la comunità degli investitori e mostrare le sue capacità commerciali complete nell'offerta di prodotti farmaceutici differenziati per i pazienti.
Assertio Holdings, una compañía farmacéutica que cotiza en Nasdaq como ASRT, ha anunciado su participación en el Maxim Group 2024 Healthcare Virtual Summit. El CEO de la compañía, Brendan O'Grady, participará en una charla informal el 15 de octubre de 2024, a la 1:00 pm hora del Este.
La discusión será moderada por el analista de investigación de Maxim Group, Naz Rahman. Los inversores interesados en escuchar el evento pueden registrarse a través del enlace proporcionado. Esta participación subraya el compromiso de Assertio con la comunidad inversionista y su capacidad para ofrecer productos farmacéuticos diferenciados a los pacientes.
Assertio Holdings, 나스닥에 ASRT로 상장된 제약 회사가 Maxim Group 2024 Healthcare Virtual Summit에 참여한다고 발표했습니다. 회사의 CEO인 Brendan O'Grady는 2024년 10월 15일 오후 1시 동부 표준시에 화상 대화에 참여할 예정입니다.
이번 논의는 Maxim Group의 연구 애널리스트인 Naz Rahman이 주관합니다. 이벤트에 참여하고자 하는 투자자들은 제공된 링크를 통해 등록할 수 있습니다. 이 참여는 Assertio가 투자 커뮤니티와의 소통에 대한 의지를 강조하고, 환자에게 차별화된 제약 제품을 제공하는 포괄적인 상업적 능력을 보여줍니다.
Assertio Holdings, une société pharmaceutique cotée au Nasdaq sous le symbole ASRT, a annoncé sa participation au Maxim Group 2024 Healthcare Virtual Summit. Le PDG de l’entreprise, Brendan O'Grady, interviendra lors d’une discussion engagée le 15 octobre 2024 à 13h00, heure de l'Est.
La discussion sera animée par Naz Rahman, analyste de recherche de Maxim Group. Les investisseurs intéressés pour écouter l'événement peuvent s'inscrire via le lien fourni. Cette participation souligne l'engagement d'Assertio envers la communauté des investisseurs et met en valeur ses capacités commerciales complètes en matière d'offres de produits pharmaceutiques différenciés pour les patients.
Assertio Holdings, ein an der Nasdaq unter ASRT gelistetes Pharmaunternehmen, hat seine Teilnahme am Maxim Group 2024 Healthcare Virtual Summit bekannt gegeben. Der CEO des Unternehmens, Brendan O'Grady, wird am 15. Oktober 2024 um 13:00 Uhr Ostzeit an einer offenen Diskussion teilnehmen.
Die Diskussion wird von Naz Rahman, dem Forschungsanalysten der Maxim Group, moderiert. Investoren, die an der Veranstaltung teilnehmen möchten, können sich über den bereitgestellten Link registrieren. Diese Teilnahme unterstreicht Assertios Engagement, mit der Investoren-Community in Kontakt zu treten und seine umfassenden kommerziellen Fähigkeiten zur Bereitstellung differenzierter pharmazeutischer Produkte für Patienten zu präsentieren.
- None.
- None.
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Brendan O’Grady, Chief Executive Officer, will participate in a fireside chat discussion as part of the Maxim Group 2024 Healthcare Virtual Summit. The fireside chat with Mr. O’Grady, hosted by Maxim Group research analyst Naz Rahman, will occur Tuesday, October 15, 2024 at 1:00 pm Eastern Time.
Investors can register to listen to the event via https://m-vest.com/events/healthcare-10152024.
About Assertio
Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.
Investor Contact
Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com
FAQ
When is Assertio (ASRT) participating in the Maxim Group Healthcare Virtual Summit?
Who will represent Assertio (ASRT) at the Maxim Group Healthcare Virtual Summit?
What type of event will Assertio's CEO participate in during the Maxim Group Healthcare Virtual Summit?
At what time is Assertio's (ASRT) fireside chat scheduled during the Maxim Group Healthcare Virtual Summit?
How can investors listen to Assertio's (ASRT) fireside chat at the Maxim Group Healthcare Virtual Summit?
